{"id":153645,"date":"2020-12-31T01:53:09","date_gmt":"2020-12-31T06:53:09","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/cyclacel-pharmaceuticals-to-present-at-biotech-showcase-digital-2021\/"},"modified":"2024-08-18T11:40:57","modified_gmt":"2024-08-18T15:40:57","slug":"cyclacel-pharmaceuticals-to-present-at-biotech-showcase-digital-2021","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/cyclacel-pharmaceuticals-to-present-at-biotech-showcase-digital-2021.php","title":{"rendered":"Cyclacel Pharmaceuticals to Present at Biotech Showcase\u2122 Digital 2021"},"content":{"rendered":"<p><![CDATA[BERKELEY HEIGHTS, N.J., Dec.  30, 2020  (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; \"Cyclacel\" or the \"Company\"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that the Company will present at Biotech Showcase\u2122 Digital 2021. The conference is taking place online between January 11-15 and will feature prerecorded sessions of company presentations. Spiro Rombotis, President & Chief Executive Officer, will provide an overview of the Company and progress in key programs.]]><\/p>\n<p>Read the rest here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2020\/12\/30\/2151650\/0\/en\/Cyclacel-Pharmaceuticals-to-Present-at-Biotech-Showcase-Digital-2021.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Cyclacel Pharmaceuticals to Present at Biotech Showcase\u2122 Digital 2021\">Cyclacel Pharmaceuticals to Present at Biotech Showcase\u2122 Digital 2021<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read the rest here: Cyclacel Pharmaceuticals to Present at Biotech Showcase\u2122 Digital 2021 <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/cyclacel-pharmaceuticals-to-present-at-biotech-showcase-digital-2021.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-153645","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/153645"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=153645"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/153645\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=153645"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=153645"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=153645"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}